Vascular calcification, especially medial artery calcification, is associated with cardiovascular death in patients with diabetes mellitus and chronic kidney disease (CKD). To determine the underlying mechanism of vascular calcification, we have demonstrated in our previous report that advanced glycation end-products (AGEs) stimulated calcium deposition in vascular smooth muscle cells (VSMCs) through excessive oxidative stress and phenotypic transition into osteoblastic cells. Since AGEs can induce apoptosis, in this study we investigated its role on VSMC apoptosis, focusing mainly on the underlying mechanisms. A rat VSMC line (A7r5) was cultured, and treated with glycolaldehyde-derived AGE-bovine serum albumin (AGE3-BSA). Apoptotic cells w...
Rationale: Vascular calcification, the formation of calcium phosphate crystals in the vessel wall, i...
We have previously shown that diabetes significantly enhances apoptosis of osteoblastic cells in viv...
Glycated and carboxy-methylated proteins do not directly activate human vascular smooth muscle cells...
Vascular calcification (VC) in macrovascular and peripheral blood vessels is one of the main factors...
senescent macroprotein derivatives formed at an accelerated rate in diabetes, are closely associated...
Background:- Diabetes mellitus (OM) is a metabolic disorder commonly associated with advanced glycat...
Microvascular complications eventually affect nearly all patients with diabetes. Advanced glycation ...
Advanced glycation endproducts (AGEs) have been reported to play a role in neointimal formation and ...
Microvascular complications eventually affect nearly all patients with diabetes. Advanced glycation ...
Microvascular complications eventually affect nearly all patients with diabetes. Advanced glycation ...
AbstractApoptosis of vascular smooth muscle cell (VSMC) plays an important role in the genesis of at...
Glycolaldehyde (GA) is a reducing sugar and a precursor of advanced glycation end products (AGEs). T...
Advanced glycation endproducts (AGEs)-induced vascular smooth muscle cell (VSMCs) proliferation and ...
<p>Advanced glycation end-products (AGEs) are involved in the development of vascular smooth muscle ...
Background. Advanced glycation end products (AGEs) accumulate in patients with diabetes, particularl...
Rationale: Vascular calcification, the formation of calcium phosphate crystals in the vessel wall, i...
We have previously shown that diabetes significantly enhances apoptosis of osteoblastic cells in viv...
Glycated and carboxy-methylated proteins do not directly activate human vascular smooth muscle cells...
Vascular calcification (VC) in macrovascular and peripheral blood vessels is one of the main factors...
senescent macroprotein derivatives formed at an accelerated rate in diabetes, are closely associated...
Background:- Diabetes mellitus (OM) is a metabolic disorder commonly associated with advanced glycat...
Microvascular complications eventually affect nearly all patients with diabetes. Advanced glycation ...
Advanced glycation endproducts (AGEs) have been reported to play a role in neointimal formation and ...
Microvascular complications eventually affect nearly all patients with diabetes. Advanced glycation ...
Microvascular complications eventually affect nearly all patients with diabetes. Advanced glycation ...
AbstractApoptosis of vascular smooth muscle cell (VSMC) plays an important role in the genesis of at...
Glycolaldehyde (GA) is a reducing sugar and a precursor of advanced glycation end products (AGEs). T...
Advanced glycation endproducts (AGEs)-induced vascular smooth muscle cell (VSMCs) proliferation and ...
<p>Advanced glycation end-products (AGEs) are involved in the development of vascular smooth muscle ...
Background. Advanced glycation end products (AGEs) accumulate in patients with diabetes, particularl...
Rationale: Vascular calcification, the formation of calcium phosphate crystals in the vessel wall, i...
We have previously shown that diabetes significantly enhances apoptosis of osteoblastic cells in viv...
Glycated and carboxy-methylated proteins do not directly activate human vascular smooth muscle cells...